Metlife reported adjusted earnings of $2.1 billion, or $2.37 per
share, for the second quarter ended June 30, from $758 million,
or 83 cents per share, a year earlier.
Analysts on average had expected a profit of $1.62 per share,
according to data from Refinitiv IBES.
The New York-based insurer said in May that the worst of the
pandemic was behind it, as a rebound in investment income helped
global life insurers offset some of the impact from payouts
related to the health crisis.
Metlife reported a 29% jump in net investment income to $5.28
billion on strong returns from private-equity investments.
Earlier in the day, Prudential Financial Inc also said the
effect of COVID-19 on its group and individual life insurance
appears to be lessening in the third quarter.
Adjusted earnings at Metlife's U.S. business jumped 72%, helping
it offset a weak performance in Latin America, Europe, the
Middle East and Africa, where its businesses were hurt by higher
COVID-19-related claims.
Adjusted earnings in its U.S. group business took a $75 million
hit from claims related to the health crisis, the insurer said.
MetLife reported net derivatives of $421 million during the
second quarter.
The insurer holds a book of derivatives to hedge against market
volatility. Such gains do not indicate the actual performance of
the company, but reflect the effect of accounting rules, an
issue that has occurred in some previous quarters.
Metlife also said its board had approved a new $3 billion share
buyback plan.
(Reporting by Noor Zainab Hussain in Bengaluru and Alwyn Scott
in New York; Editing by Devika Syamnath)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|